Echo FLOW Versus (Non-)Invasive Haemodynamics
EFLOW
The Accuracy of Ultrasound Derived Carotid, Femoral and Brachial Artery Compared to Conventional Intra-vascular Methods Flow-related Parameters
1 other identifier
observational
20
1 country
1
Brief Summary
Rationale: Diligent fluid management is instrumental to improve postoperative outcome, cost and quality of care. Objective: To determine the accuracy of brachial, femoral and carotid blood flow measurement with ultrasound compared to intermittent transpulmonary thermodilution cardiac output measurement, invasive and non-invasive pulse-contour analysis. Study design: Observational study - Prospective clinical non-intervention measurement study. Study population: Adult ASA 1-2 patients, scheduled for open upper GI surgery Intervention (if applicable): Not applicable. We will perform non-invasive ultrasound measurements of the femoral, carotid and brachial blood flow right before induction and under anaesthesia. Main study parameters/endpoints: Femoral, carotid and brachial blood flow determined by ultrasound and blood flow variation and the accuracy compared to transpulmonary thermodilution cardiac output, stroke volume variation, and pulse-contour analysis derived cardiac output (invasive or non-invasive) at the following time points during surgery; (limited for femoral site as it cannot be measured during surgery): (1) before induction of anaesthesia, (2) after induction, (3) 15 minutes after start of surgery, (4) before and (5) after (1-2 minutes) a fluid bolus, (6) before and (7) after start of vasopressors, (8) before and (9) after Trendelenburg position and (10) after surgery before end of anaesthesia (figure 1). A fluid bolus will be performed as part of standard care (goal-directed fluid therapy). The vasopressor and Trendelenburg position time points are optional measurements. We will also measure (continuous) invasive femoral blood pressure (SBP, DBP, MAP), non-invasive blood pressure, SVV, central venous pressure (when available), heart rate, SpO2, PFI, etCO2.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 9, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 9, 2019
CompletedFirst Submitted
Initial submission to the registry
September 29, 2020
CompletedFirst Posted
Study publicly available on registry
October 20, 2020
CompletedOctober 20, 2020
October 1, 2020
9 months
September 29, 2020
October 19, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Cardiac output
blood flow determined by ultrasound and the accuracy compared to transpulmonary thermodilution calibrated continuous cardiac output
baseline
Secondary Outcomes (1)
Cardiac output change
change from baseline cardiac output 1 minute after intervention (fluid challenge, vasopressor administration, or Trendelenburg)
Study Arms (1)
Patients undergoing major upper abdominal surgery
major open upper abdominal surgery eg pancreatic, liver surgery
Interventions
carotid blood flow measurement with ultrasound vs transpulmonary thermodilution calibrated continuous cardiac output measurements
Eligibility Criteria
Adult patients, scheduled for open upper GI surgery with a American Society of Anaesthesiologist score of 1 to 2
You may qualify if:
- Elective open GI surgery
- Invasive arterial blood pressure monitoring
- Informed consent
You may not qualify if:
- Significant stenosis \> 30% or abnormal anatomy of aortic, femoral, carotid or brachial artery
- Cerebrovascular accident
- Atrial fibrillation
- COPD stage 3-4
- Lobectomy / pneumectomy
- Active pneumonia
- Cardiac failure
- Severe heart valve regurgitation or stenosis
- Not able to measure brachial or carotid artery blood flow during surgery
- Contra-indications for femoral arterial catheter placement (e.g., vascular graft)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Academisch Medisch Centrum - Universiteit van Amsterdam
Amsterdam, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
A.P. Vlaar, MD, PhD
Amsterdam UMC
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 29, 2020
First Posted
October 20, 2020
Study Start
April 19, 2018
Primary Completion
January 9, 2019
Study Completion
January 9, 2019
Last Updated
October 20, 2020
Record last verified: 2020-10